1 A OZGEN, MD , 2M N ALP , MD , 1M ARIYUREK , MD, 3N B TUTUNCU, MD 2 I CAN ,MD and 4I GUNALP ,MD
1放射科3内分泌科,Hacettepe 大学,医学部,安卡拉,Sihhiye
2眼科,Numune医院,安卡拉,Sihhiye, 安卡拉大学医学部,土耳其,安卡拉,Cebeci
表4.Graves’眼病中突眼的存在和眼外肌增大的形式
形式 眶部数量
(n=174)
M E 16(9)
E 15(9)
All E 12(7)
M 10
IR SMG MR E 9(5)
SMG E 8(5)
M, 内直肌; E, 突眼; All, 全部眼外肌; IR, 下直肌; SMG, 上肌群.
括号内数字代表百分比.只列出了发生百分率≥5%的样本.
参考文献
1. Weber AL, Dallow RL, Sabates NR. Graves’ disease of the orbit. Neuroimaging Clin North Am 1996;6:61-72.
2. Nugent RA, Belkin RI, Neigel JM, Rootman J, Robertson WD, Spinelli J, et al. Graves’ orbitopathy: correlation of CT and clinical
Findings.Radiology 1990;177:675-82.
3. Birchall D,Goodall KL,Noble JL,Jacksong A. Graves’ ophthalmopathy: intracranial fat prolapse on CT images as an indicator of optic nerve compression. Radiology 1996;200:123-7
4. Yeatts RP. Graves’ ophthalmopathy. Med Clin North Am 1995;79:195-209.
5. özgen A, Ariyürek M. Normative measurement of orbital structure using CT. AJR 1998;170:1093-6.
6. Carter JA, Utiger RD. The ophthalmopathy of Graves’ disease. Annual Rev Med 1992;43:487-95.
7. Forbes G, Gorman CA , Brennan MD, Gehiing DG, Ilstrup DM, Earnest F. Ophthalmopathy of Graves’ disease : computerized volume measurements of the orbital fat and muscle. An J Neuroradiol 1986;7:651-6.
8. Uhlenbrock D. Computerized tomography in Graves’ ophthalmopathy----evaluation regarding the muscle size and density units. Neurosurg Rev 1988;11:45-51.
9. Tallstedt L, Lundell G , Torring O, Wallin G, Ljunggren JG, Blomgren H, et al . Occurrence of ophthamopathy after treatment for Graves’ hyperthyroidism. New Engl J Med 1992;326:1733-8.
10. Hurley JR . Orbitopathy after treatment of Graves’ disease . J Nucl Med 1994;35:918-20.